{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:32:05Z","timestamp":1780979525524,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K07175"],"award-info":[{"award-number":["17K07175"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejphar.2021.174373","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T04:12:32Z","timestamp":1626927152000},"page":"174373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells"],"prefix":"10.1016","volume":"908","author":[{"given":"Chie","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174373_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2021.174373_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","article-title":"Myc and cell cycle control","volume":"1849","author":"Bretones","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174373_bib3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1069398","article-title":"Genomic instability in mice lacking histone H2AX","volume":"296","author":"Celeste","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.174373_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.critrevonc.2018.06.004","article-title":"Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma","volume":"128","author":"Elmaci","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejphar.2021.174373_bib5","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3389\/fmicb.2017.02686","article-title":"Hijacking of the AP-1 signaling pathway during development of ATL","volume":"8","author":"Gazon","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2021.174373_bib6","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","article-title":"Molecular mechanisms of apoptosis and roles in cancer development and treatment","volume":"16","author":"Goldar","year":"2015","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ejphar.2021.174373_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1440-1681.13049","article-title":"Inhibition of cancer stem cells promoted by Pimozide","volume":"46","author":"Gon\u00e7alves","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2021.174373_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/OTT.S147316","article-title":"Quercetin suppresses DNA double-strand break repair and enhances the radiosensitivity of human ovarian cancer cells via p53-dependent endoplasmic reticulum stress pathway","volume":"11","author":"Gong","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2021.174373_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/cdd.2017.65","article-title":"Initiation and execution mechanisms of necroptosis: an overview","volume":"24","author":"Grootjans","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2021.174373_bib10","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1242\/jcs.01589","article-title":"AP-1 subunits: quarrel and harmony among siblings","volume":"117","author":"Hess","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2021.174373_bib11","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3390\/cancers12082185","article-title":"The role of necroptosis in ROS-mediated cancer therapies and its promising applications","volume":"12","author":"Hsu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2021.174373_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172953","article-title":"Evaluation of artesunate for the treatment of adult T-cell leukemia\/lymphoma","volume":"872","author":"Ishikawa","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174373_bib13","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2021.174373_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2021.174373_bib15","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/sj.onc.1204304","article-title":"Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I","volume":"20","author":"Iwanaga","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174373_bib16","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/onc.2008.174","article-title":"Activation of the cyclin D2 and cdk6 genes through NF-\u03baB is critical for cell-cycle progression induced by HTLV-I Tax","volume":"27","author":"Iwanaga","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174373_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ijc.20954","article-title":"Transcriptional activation of survivin through the NF-\u03baB pathway by human T-cell leukemia virus type I tax","volume":"115","author":"Kawakami","year":"2005","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejphar.2021.174373_bib18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2741\/3319","article-title":"Cell signaling modifiers for molecular targeted therapy in ATLL","volume":"14","author":"Mori","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2021.174373_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jech.43.1.43","article-title":"The incidence of cancer in schizophrenic patients","volume":"43","author":"Mortensen","year":"1989","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.ejphar.2021.174373_bib20","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","article-title":"Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia","volume":"27","author":"Nakayama","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174373_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4939-6872-5_15","article-title":"Overview of targeted therapies for adult T-cell leukemia\/lymphoma","volume":"1582","author":"Nasr","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2021.174373_bib22","first-page":"155","article-title":"Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients","volume":"67","author":"Neifeld","year":"1983","journal-title":"Canc. Treat Rep."},{"key":"10.1016\/j.ejphar.2021.174373_bib23","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2021.174373_bib24","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-\u03baB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174373_bib25","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174373_bib26","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1940-6207.CAPR-10-0037","article-title":"Thiocolchicoside exhibits anticancer effects through downregulation of NF-\u03baB pathway and its regulated gene products linked to inflammation and cancer","volume":"3","author":"Reuter","year":"2010","journal-title":"Canc. Prev. Res."},{"key":"10.1016\/j.ejphar.2021.174373_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Tabas","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174373_bib28","doi-asserted-by":"crossref","first-page":"13897","DOI":"10.1073\/pnas.94.25.13897","article-title":"Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins","volume":"94","author":"Takemoto","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2021.174373_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(79)91025-0","article-title":"Treatment of metastatic malignant melanoma with pimozide","volume":"1","author":"Taub","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.174373_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174373_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2010.07.016","article-title":"Targeting ER stress induced apoptosis and inflammation in cancer","volume":"332","author":"Verfaillie","year":"2013","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2021.174373_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The potential and controversy of targeting STAT family members in cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.ejphar.2021.174373_bib33","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","article-title":"NF-\u03baB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation","volume":"281","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.174373_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","article-title":"Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target","volume":"126","author":"Wiklund","year":"2010","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejphar.2021.174373_bib35","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.4049\/jimmunol.157.9.3980","article-title":"A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells","volume":"157","author":"Zhang","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2021.174373_bib36","doi-asserted-by":"crossref","first-page":"59950","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:57:18Z","timestamp":1757977038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921005264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"alternative-id":["S0014299921005264"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174373","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174373"}}